by Stacey Johnson | Feb 23, 2024
As a fair-skinned, freckled person (my mom says she painted them on me while I slept), and one who has a family history of skin cancers and melanoma, the news on February 19 that Iovance Biotherapeutics’ AMTAGVITM received U.S. Food and Drug Administration (FDA)...
by Tyler Wenzel | Dec 21, 2023
I can recall the first time that I heard about the idea of gene therapy. It was over 20 years ago, and possibly like many students in school, I was assigned to write an essay on the ethical considerations for allowing or disallowing gene editing on humans. I remember...
by Tyler Wenzel | Nov 23, 2023
Cell therapies that replenish a healthy cell niche have long been an attractive approach to treat a variety of diseases, such as Parkinson’s disease, which are incurable and characterized by the loss of critical cell functions. The attractiveness of cell therapies is...
by Kevin Robb | Nov 9, 2023
BlueRock Therapeutics has generated considerable media buzz with their announcement of positive Phase I clinical trial data on bemdaneprocel (BRT-DA01), an investigational, stem cell-derived, dopaminergic therapy for Parkinson’s disease. The trial is the result of...
by CCRM Australia | Oct 6, 2023
This blog post was written by Jimmy Yu (see LinkedIn page) with supervision by Dr. Chih Wei Teng. Traditional medicine and the practices of Australia’s First Nations – Australian Aboriginal people and Torres Strait Islander – embody a world imbued with ancient...
by Peace Chukwu | Sep 14, 2023
The ability to regrow teeth after a certain age would be monumental to solving most of our dental problems. Unlike other animals like sharks and alligators that can replace their teeth dozens of times, or the kangaroos and elephants – all polyphyodonts – humans are...
Comments